Fipamezole clinical trials
Also written JP-1730.
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2002
How each study uses fipamezole is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
3 studies that test it; most in 2002 (1)
| Year | Studies |
|---|---|
| 2002 | 1 |
| 2007 | 1 |
| 2008 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 2
- 3
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 2 · Other 1
Juvantia Pharma Ltd (2) · National Institute of Neurological Disorders and Stroke (NINDS) (1)
Studies
Open first, then newest update. How each study uses fipamezole is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- Safety and Efficacy Study of Fipamezole in Treatment of Motor Dysfunctions in Parkinson's DiseaseCompletedPhase 2Juvantia Pharma LtdNCT00559871Written as fipamezole
- Fipamezole in Neurogenic Orthostatic HypotensionStatus unknownPhase 2Juvantia Pharma LtdNCT00758849Written as Fipamezole
- JP-1730 to Treat Parkinson's DiseaseCompletedPhase 2National Institute of Neurological Disorders and Stroke (NINDS)NCT00040209Written as JP 1730
Codes
What other systems call fipamezole · ClinicalTrials.gg INT004603
- MeSH (NLM) C480818fipamezoleOne source NLM
- UNII (FDA) T5RCK09KHVFIPAMEZOLEConfirmed FDA, NLM, Wikidata
- Wikidata Q27289711fipamezoleConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C65684FipamezoleOne source FDA
- DrugBank DB06585One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C480818 | fipamezole | One source NLM |
| UNII (FDA) | T5RCK09KHV | FIPAMEZOLE | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q27289711 | fipamezole | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C65684 | Fipamezole | One source FDA |
| DrugBank | DB06585 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.